Dihexa is a small molecule peptide derived from angiotensin IV, specifically designed to enhance cognitive function and synaptic connectivity. Researchers primarily study it for its potential role in addressing neurodegenerative diseases, such as Alzheimer's disease, by promoting neuroplasticity and memory consolidation. Key findings indicate that Dihexa activates the hepatocyte growth factor/c-Met receptor system, leading to increased synaptogenesis and improved cognitive performance in animal models. Preclinical evidence suggests that this compound is orally active and capable of penetrating the blood-brain barrier, which enhances its therapeutic potential. Current research is focused on further elucidating its mechanisms of action and evaluating its efficacy in clinical settings.